Document text
Principal Investigator: Debra Parker Oliver
Organization: WASHINGTON UNIVERSITY
Fiscal Year: 2024
Award: $732,899
Funding agency: National Institute on Aging
Caregiver Speaks: A Technologically Mediated Storytelling Intervention for Family Caregivers of
Individuals with Alzheimer’s Disease and Other Dementias
ABSTRACT
This randomized controlled trial will test an intervention for an understudied population – family caregivers of
persons living with dementia (PLWD). This project is the first of its kind to longitudinally follow family caregivers
of PLWD into bereavement. Furthermore, the intervention, Caregiver Speaks, employs an innovative
storytelling approach – photo elicitation (the use of photos to elicit thoughts, feelings, and reactions to a
person’s experience) – to encourage family caregivers to make meaning of their caregiving and bereavement
experiences as a way of reducing depression, anxiety, and ultimately grief intensity. Caregiver Speaks is
deployed via a readily available social media network (Facebook), which allows easy access for already
overburdened family caregivers of PLWD, and can improve their social support. Preliminary work
demonstrates that 1) this project is feasible as an RCT intervention study of caregiver experiences, 2) the
research team can conduct this type of storytelling intervention via Facebook, and 3) family caregivers use
(and want to use) social media during active caregiving and into bereavement, despite their heavy care
burdens. The research team will base the proposal on Park and Folkman’s meaning-making model of stress
and coping. This model illustrates how individuals cope with adverse life events (i.e., trauma, or death of a
loved one) by reconstructing and transforming the event’s meaning and incorporating the reappraised meaning
into one’s larger self-narrative. Caregiver Speaks uses storytelling in the form of photo-elicitation, in order to
facilitate this meaning-making. Caregivers share photos and discussions regarding their caregiving and
bereavement experiences in a private, facilitated Facebook group. This model suggests that caregivers’ ability
to make sense of (meaning making), and find benefit in an adverse life situation (caregiving and bereavement)
will be validated through social support, and result in reduced depression, anxiety, and grief intensity.
Caregivers will be randomly assigned to either: 1) Group 1, which will receive the Caregiver Speaks
intervention, or 2) Group 2, which will receive standard care, including the standard care for bereavement. The
research team will use both quantitative and qualitative methods in parallel and equal status to measure the
intervention’s efficacy. The overall hypothesis is that participating in Caregiver Speaks during caregiving and
into bereavement will reduce caregivers’ depression and anxiety, and as a result will reduce grief intensity in
bereavement. The three specific aims are to: 1) determine the efficacy of the Caregiver Speaks
intervention in reducing depression and anxiety among family caregivers of people with dementia, 2)
examine the intervention’s effect on grief intensity among bereaved family caregivers of people with
dementia, and 3) describe how caregivers made meaning of their caregiving and bereavement
experiences.
Terms: <AD dementia><Address><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimers Dementia><Amentia><American><Anxiety><Behavior Conditioning Therapy><Behavior Modification><Behavior Therapy><Behavior Treatment><Behavioral><Behavioral Conditioning Therapy><Behavioral Modification><Behavioral Therapy><Behavioral Treatment><Bereavement><Bereavement Care><Care Givers><Caregivers><Caring><Cessation of life><Conditioning Therapy><Control Groups><Death><Decision Making><Dementia><Dementia caregivers><Distress><Environment><Event><Facebook><Family Care Giver><Family Caregiver><Feeling><Goals><Grief><Grief reaction><Health Insurance for Aged and Disabled, Title 18><Health Insurance for Disabled Title 18><Hospices><Individual><Intervention><Intervention Strategies><Intervention Studies><Life><Measures><Mediating><Medicare><Mental Depression><Methods><Mission><Modeling><NIH><National Institutes of Health><Outcome><Patients><Persons><Population><Primary Senile Degenerative Dementia><Privatization><Qualitative Methods><Qualitative Research><Randomized><Randomized, Controlled Trials><Reaction><Reporting><Research><Research Resources><Resources><Services><Site><Social Impacts><Social support><Stress and Coping><Technology><Testing><Thinking><Title 18><Trauma><Treatment Efficacy><United States National Institutes of Health><Work><age associated><age associated disease><age associated disorder><age associated impairment><age correlated><age dependent><age dependent disease><age dependent disorder><age dependent impairment><age linked><age related><age related human disease><age specific><age-related disease><age-related disorder><age-related impairment><arm><base><bases><behavior intervention><behavioral intervention><burden on families><burden to families><care burden><care giver depression><care giving><caregiver depression><caregivers for persons living with dementia><caregivers for persons with dementia><caregivers of individuals with dementia><caregivers of patients with dementia><caregiving><coping><coping with stress><dementia care giver><depression><determine efficacy><efficacy analysis><efficacy assessment><efficacy determination><efficacy evaluation><efficacy examination><empowerment><evaluate efficacy><examine efficacy><experience><familial burden><family burden><feelings><group intervention><health care service><health insurance for disabled><healthcare service><hospice environment><improved><innovate><innovation><innovative><insight><interest><intervention effect><intervention efficacy><intervention research><interventional research><interventional strategy><interventional study><interventions research><loved ones><primary degenerative dementia><qualitative reasoning><randomisation><randomization><randomized control trial><randomly assigned><senile dementia of the Alzheimer type><social><social media><social support network><standard care><standard treatment><stress-related coping><therapeutic efficacy><therapy efficacy><thoughts>